{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:26:02Z","timestamp":1773296762974,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.pupt.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T16:34:13Z","timestamp":1533227653000},"page":"7-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort\u00ae (budesonide\/formoterol) pressurized metered dose inhaler"],"prefix":"10.1016","volume":"52","author":[{"given":"Michael","family":"Gillen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-7067","authenticated-orcid":false,"given":"Pablo","family":"Forte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Olof","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Lamarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Rask","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrika","family":"Larsdotter Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Eckerwall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pupt.2018.08.001_bib1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","article-title":"Inhaler mishandling remains common in real life and is associated with reduced disease control","volume":"105","author":"Melani","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.08.001_bib2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2147\/COPD.S85681","article-title":"Evaluating inhaler use technique in COPD patients","volume":"10","author":"Pothirat","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"2","key":"10.1016\/j.pupt.2018.08.001_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1183\/09031936.02.00218402","article-title":"Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability","volume":"19","author":"Giraud","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.08.001_bib4","series-title":"Pocket Guide for Asthma Management and Prevention (For Adults and Children Older than 5 Years): a Pocket Guide for Health Professionals","author":"Global Initiative for Asthma","year":"2017"},{"issue":"4","key":"10.1016\/j.pupt.2018.08.001_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/jamp.2015.1232","article-title":"The evolution of pressurized metered-dose inhalers from early to modern devices","volume":"29","author":"Roche","year":"2016","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"2","key":"10.1016\/j.pupt.2018.08.001_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1378\/chest.117.2.542","article-title":"Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique","volume":"117","author":"Cochrane","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.08.001_bib7","series-title":"Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","year":"2017"},{"issue":"6","key":"10.1016\/j.pupt.2018.08.001_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/thx.49.6.549","article-title":"Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices","volume":"49","author":"Hindle","year":"1994","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pupt.2018.08.001_bib9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1183\/09031936.03.00027003","article-title":"Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease","volume":"22","author":"Calverley","year":"2003","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2018.08.001_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09031936.03.00031402","article-title":"Efficacy and safety of budesonide\/formoterol in the management of chronic obstructive pulmonary disease","volume":"21","author":"Szafranski","year":"2003","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.pupt.2018.08.001_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.rmed.2011.07.020","article-title":"Effect of budesonide\/formoterol pMDI on COPD exacerbations: a double-blind, randomized study","volume":"106","author":"Sharafkhaneh","year":"2012","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.pupt.2018.08.001_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1742-1241.2007.01338.x","article-title":"Effect of budesonide\/formoterol maintenance and reliever therapy on asthma exacerbations","volume":"61","author":"Kuna","year":"2007","journal-title":"Int. J. Clin. Pract."},{"issue":"5","key":"10.1016\/j.pupt.2018.08.001_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.clinthera.2007.05.011","article-title":"Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma","volume":"29","author":"Corren","year":"2007","journal-title":"Clin. Therapeut."},{"issue":"14","key":"10.1016\/j.pupt.2018.08.001_bib14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2165\/00003495-200868140-00004","article-title":"Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial","volume":"68","author":"Tashkin","year":"2008","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.pupt.2018.08.001_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1742-1241.2002.tb11378.x","article-title":"Symbicort Turbuhaler: a new concept in asthma management","volume":"56","author":"Kuna","year":"2002","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.pupt.2018.08.001_bib16","series-title":"Symbicort Turbohaler 100\/6, Inhalation Powder Summary of Product Characteristics","author":"AstraZeneca","year":"2017"},{"key":"10.1016\/j.pupt.2018.08.001_bib17","series-title":"Guideline on the Pharmaceutical Quality of Inhalation and Nasal Products","first-page":"1","author":"(CHMP), C.f.M.P.f.H.U","year":"2006"},{"issue":"10","key":"10.1016\/j.pupt.2018.08.001_bib18","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1183\/09031936.94.07101839","article-title":"Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI","volume":"7","author":"Thorsson","year":"1994","journal-title":"Eur. Respir. J."},{"issue":"Suppl 58","key":"10.1016\/j.pupt.2018.08.001_bib19","first-page":"1891","article-title":"Pearl's PT010 triple combination provides comparable budesonide exposure to symbicort and comparable glycopyrronium and formoterol exposure to PT003","volume":"44","author":"Reisner","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.pupt.2018.08.001_bib20","first-page":"489","article-title":"Canadian Standards Association standard CAN\/CSA\/Z264.1-02:2002: a new voluntary standard for spacers and holding chambers used with pressurized metered-dose inhalers","volume":"11","author":"Dolovich","year":"2004","journal-title":"Canc. Res. J."},{"issue":"7","key":"10.1016\/j.pupt.2018.08.001_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/bdd.622","article-title":"Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults","volume":"29","author":"Eklund","year":"2008","journal-title":"Biopharm Drug Dispos."},{"issue":"6","key":"10.1016\/j.pupt.2018.08.001_bib22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1365-2125.2011.04024.x","article-title":"Effect of AeroChamber Plus on the lung and systemic bioavailability of beclometasone dipropionate\/formoterol pMDI","volume":"72","author":"Singh","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.pupt.2018.08.001_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/02786829408959756","article-title":"Characterization of medical aerosols: physical and clinical requirements for new inhalers","volume":"22","author":"Dolovich","year":"1995","journal-title":"Aerosol. Sci. Technol."},{"issue":"11","key":"10.1016\/j.pupt.2018.08.001_bib24","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1177\/0091270008322122","article-title":"Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD","volume":"48","author":"Tronde","year":"2008","journal-title":"J. Clin. Pharmacol."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553917303000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553917303000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T03:58:45Z","timestamp":1693799925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553917303000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":24,"alternative-id":["S1094553917303000"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2018.08.001","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort\u00ae (budesonide\/formoterol) pressurized metered dose inhaler","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 AstraZeneca, UK, Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}